Literature DB >> 8912676

Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle.

S O'Driscoll1, T V McCarthy, H M Eichinger, W Erhardt, F Lehmann-Horn, A Herrmann-Frank.   

Abstract

Ca2+ release from sarcoplasmic reticulum (SR) of malignant-hyperthermia-susceptible (MHS) muscle is hypersensitive to Ca2+ and caffeine. To determine if an abnormal calmodulin (CaM) regulation of the SR Ca(2+)-release-channel-ryanodine-receptor complex (RYR1) contributes to this hypersensitivity, we investigated the effect of CaM on high-affinity [3H]ryanodine binding to isolated SR vesicles from normal and MHS pig skeletal muscle. CaM modulated [3H]ryanodine binding in a Ca(2+)-dependent manner. In the presence of maximally activating Ca2+ concentrations, CaM inhibited [3H]ryanodine binding with no differences between normal and MHS vesicles. In the absence of Ca2+, however, CaM activated [3H]ryanodine binding with a 2-fold-higher potency in MHS vesicles. Significant differences between normal and MHS tissue were observed for CaM concentrations between 50 nM and 10 microM. A polyclonal antibody raised against the central region of RYR1 specifically inhibited this activating effect of CaM without affecting the inhibition by CaM. This indicates that the central region of RYR1 is a potential binding domain for CaM in the absence of Ca2+. It is suggested that in vivo an enhanced CaM sensitivity of RYR1 might contribute to the abnormal high release of Ca2+ from the SR of MHS muscle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912676      PMCID: PMC1217785          DOI: 10.1042/bj3190421

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle.

Authors:  M Michalak; P Dupraz; V Shoshan-Barmatz
Journal:  Biochim Biophys Acta       Date:  1988-04-22

2.  Inhibition of calcium release from skeletal muscle sarcoplasmic reticulum by calmodulin.

Authors:  B Plank; W Wyskovsky; M Hohenegger; G Hellmann; J Suko
Journal:  Biochim Biophys Acta       Date:  1988-02-08

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  Malignant hyperthermia.

Authors:  D H MacLennan; M S Phillips
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

5.  Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia.

Authors:  J R Mickelson; E M Gallant; L A Litterer; K M Johnson; W E Rempel; C F Louis
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

Review 6.  Calmodulin.

Authors:  C B Klee; T C Vanaman
Journal:  Adv Protein Chem       Date:  1982

7.  Calmodulin interaction with the skeletal muscle sarcoplasmic reticulum calcium channel protein.

Authors:  H C Yang; M M Reedy; C L Burke; G M Strasburg
Journal:  Biochemistry       Date:  1994-01-18       Impact factor: 3.162

8.  Evidence of a role for calmodulin in the regulation of calcium release from skeletal muscle sarcoplasmic reticulum.

Authors:  G Meissner
Journal:  Biochemistry       Date:  1986-01-14       Impact factor: 3.162

9.  Enhanced Ca2+-induced calcium release by isolated sarcoplasmic reticulum vesicles from malignant hyperthermia susceptible pig muscle.

Authors:  J R Mickelson; J A Ross; B K Reed; C F Louis
Journal:  Biochim Biophys Acta       Date:  1986-11-17

10.  Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides.

Authors:  I N Pessah; R A Stambuk; J E Casida
Journal:  Mol Pharmacol       Date:  1987-03       Impact factor: 4.436

View more
  6 in total

Review 1.  Caffeine and excitation-contraction coupling in skeletal muscle: a stimulating story.

Authors:  A Herrmann-Frank; H C Lüttgau; D G Stephenson
Journal:  J Muscle Res Cell Motil       Date:  1999-02       Impact factor: 2.698

2.  Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.

Authors:  S S Palnitkar; J R Mickelson; C F Louis; J Parness
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

3.  Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation.

Authors:  B M Manning; K A Quane; H Ording; A Urwyler; V Tegazzin; M Lehane; J O'Halloran; E Hartung; L M Giblin; P J Lynch; P Vaughan; K Censier; D Bendixen; G Comi; L Heytens; K Monsieurs; T Fagerlund; W Wolz; J J Heffron; C R Muller; T V McCarthy
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

4.  S100A1 and calmodulin compete for the same binding site on ryanodine receptor.

Authors:  Nathan T Wright; Benjamin L Prosser; Kristen M Varney; Danna B Zimmer; Martin F Schneider; David J Weber
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

5.  Pharmacological clues to calmodulin-mediated activation of skeletal ryanodine receptor using [3H]-ryanodine binding.

Authors:  E Damiani; A Margreth
Journal:  J Muscle Res Cell Motil       Date:  2000-01       Impact factor: 2.698

Review 6.  Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Authors:  Tokunbor A Lawal; Emily S Wires; Nancy L Terry; James J Dowling; Joshua J Todd
Journal:  Orphanet J Rare Dis       Date:  2020-05-07       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.